Targeting renal cell carcinoma with radiolabeled antibodies

S. Muselaers

Promotor: P.F.A Mulders and O.C. Boerman and W.J.G. Oyen
Radboud Universiteit Nijmegen
May 22, 2015


The aim of this thesis was to further optimize the detction and treatment of ccRCC using radiolabeled mAb cG250/girentuximab. The preclinical and clinical studies presented in this thesis focus on detection of ccRCC with Indium-111 ( 111 In) labeled girentuximab and treatment of advanced disease with Lutetium-177 ( 177 Lu)-girentuximab. In addition, the feasibility of novel fluorescence imaging techniques for ccRCC which may ultimately lead to intraoperative detection of ccRCC lesions was evaluated.

A pdf file of this publication is available for personal use. Enter your e-mail address in the box below and press the button. You will receive an e-mail message with a link to the pdf file.